{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:24:55Z","timestamp":1792664695259,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00428-026-04556-5","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:00:54Z","timestamp":1777960854000},"page":"1187-1201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aggressive follicular cell derived thyroid carcinoma: what do you need from the pathologist"],"prefix":"10.1007","volume":"488","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6200-0231","authenticated-orcid":false,"given":"Theresa","family":"Scognamiglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"4556_CR1","doi-asserted-by":"publisher","first-page":"152678","DOI":"10.1016\/j.prp.2019.152678","volume":"216","author":"S Agarwal","year":"2020","unstructured":"Agarwal S, Sadiq Q, Ortanca I (2020) Hobnail cells in encapsulated papillary thyroid carcinoma: Report of 2 cases with immunohistochemical and molecular findings and literature analysis. Pathol Res Pract 216:152678. https:\/\/doi.org\/10.1016\/j.prp.2019.152678","journal-title":"Pathol Res Pract"},{"key":"4556_CR2","first-page":"1902","volume":"88","author":"LA Akslen","year":"2000","unstructured":"Akslen LA, LiVolsi VA (2000) Prognostic significance of histologic grading compared with subclassification of papillary. thyroid carcinoma Cancer 88:1902\u20131908","journal-title":"thyroid carcinoma Cancer"},{"key":"4556_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/0959-8049(93)90574-y","volume":"29A","author":"LA Akslen","year":"1992","unstructured":"Akslen LA, Myking AO, Salvesen H, Varhaug JE (1992) Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 29A:44\u201351. https:\/\/doi.org\/10.1016\/0959-8049(93)90574-y","journal-title":"Eur J Cancer"},{"key":"4556_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.20945\/2359-3997000000245","volume":"64","author":"MFO Almeida","year":"2020","unstructured":"Almeida MFO, Couto JS, Ticly ALT, Guardia VC, Marone MMS, Scalissi NM, Cury AN, Ferraz C, Padovani RDP (2020) The impact of minimal extrathyroidal extension in the recurrence of papillary thyroid cancer patients. Arch Endocrinol Metab 64:251\u2013256. https:\/\/doi.org\/10.20945\/2359-3997000000245","journal-title":"Arch Endocrinol Metab"},{"key":"4556_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/PAS.0000000000000329","volume":"39","author":"AM Amacher","year":"2015","unstructured":"Amacher AM, Goyal B, Lewis JS Jr., El-Mofty SK, Chernock RD (2015) Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation. Am J Surg Pathol 39:260\u2013265. https:\/\/doi.org\/10.1097\/PAS.0000000000000329","journal-title":"Am J Surg Pathol"},{"key":"4556_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12022-017-9502-7","volume":"28","author":"F Ambrosi","year":"2017","unstructured":"Ambrosi F, Righi A, Ricci C, Erickson LA, Lloyd RV, Asioli S (2017) Hobnail Variant of Papillary Thyroid Carcinoma: a Literature. Rev Endocr Pathol 28:293\u2013301. https:\/\/doi.org\/10.1007\/s12022-017-9502-7","journal-title":"Rev Endocr Pathol"},{"key":"4556_CR7","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1245\/s10434-018-6563-x","volume":"25","author":"M Amit","year":"2018","unstructured":"Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo ME (2018) Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer? Ann Surg Oncol 25:3380\u20133388. https:\/\/doi.org\/10.1245\/s10434-018-6563-x","journal-title":"Ann Surg Oncol"},{"key":"4556_CR8","doi-asserted-by":"publisher","unstructured":"Arora N, Turbendian HK, Scognamiglio T, Wagner PL, Goldsmith SJ, Zarnegar R, Fahey TJ 3 (2008) rd Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma. Surgery 144:942\u2013947; discussion 947\u2013948. https:\/\/doi.org\/10.1016\/j.surg.2008.07.023","DOI":"10.1016\/j.surg.2008.07.023"},{"key":"4556_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/PAS.0b013e3181c46677","volume":"34","author":"S Asioli","year":"2010","unstructured":"Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV (2010) Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol 34:44\u201352. https:\/\/doi.org\/10.1097\/PAS.0b013e3181c46677","journal-title":"Am J Surg Pathol"},{"key":"4556_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.humpath.2012.06.003","volume":"44","author":"S Asioli","year":"2013","unstructured":"Asioli S, Erickson LA, Righi A, Lloyd RV (2013) Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol 44:320\u2013328. https:\/\/doi.org\/10.1016\/j.humpath.2012.06.003","journal-title":"Hum Pathol"},{"key":"4556_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simoes M, Tallini G, Mete O (2022) Overview of the 2022 WHO Classification of. Thyroid Neoplasms Endocr Pathol 33:27\u201363. https:\/\/doi.org\/10.1007\/s12022-022-09707-3","journal-title":"Thyroid Neoplasms Endocr Pathol"},{"key":"4556_CR12","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.surg.2013.05.009","volume":"154","author":"T Beninato","year":"2013","unstructured":"Beninato T, Scognamiglio T, Kleiman DA, Uccelli A, Vaca D, Fahey TJ 3rd, Zarnegar R (2013) 10% tall cells confer the aggressive features of the tall cell variant of papillary. thyroid carcinoma Surg 154:1331\u20131336 discussion 1336. https:\/\/doi.org\/10.1016\/j.surg.2013.05.009","journal-title":"thyroid carcinoma Surg"},{"key":"4556_CR13","volume-title":"Endocrine and Neuroendocrine Tumours","author":"Board WCoTE","year":"2022","unstructured":"Board WCoTE (2022) Endocrine and Neuroendocrine Tumours. International Agency for Research on Cancer, Lyon France"},{"key":"4556_CR14","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1245\/s10434-019-07444-2","volume":"26","author":"PJ Bongers","year":"2019","unstructured":"Bongers PJ, Kluijfhout WP, Verzijl R, Lustgarten M, Vermeer M, Goldstein DP, Devon K, Rotstein LE, Asa SL, Brierley JD, Tsang RW, Ezzat S, Vriens MR, Mete O, Pasternak JD (2019) Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk Disease. Ann Surg Oncol 26:2533\u20132539. https:\/\/doi.org\/10.1245\/s10434-019-07444-2","journal-title":"Ann Surg Oncol"},{"key":"4556_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/1066896914531814","volume":"22","author":"M Bongiovanni","year":"2014","unstructured":"Bongiovanni M, Mazzucchelli L, Giovanella L, Frattini M, Pusztaszeri M (2014) Well-differentiated follicular patterned tumors of the thyroid with high-grade features can metastasize in the absence of capsular or vascular invasion: report of a case Int. J Surg Pathol 22:749\u2013756. https:\/\/doi.org\/10.1177\/1066896914531814","journal-title":"J Surg Pathol"},{"key":"4556_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejca.2018.12.003","volume":"108","author":"C Bournaud","year":"2019","unstructured":"Bournaud C, Descotes F, Decaussin-Petrucci M, Berthiller J, de la Fouchardiere C, Giraudet AL, Bertholon-Gregoire M, Robinson P, Lifante JC, Lopez J, Borson-Chazot F (2019) TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma. Eur J Cancer 108:41\u201349. https:\/\/doi.org\/10.1016\/j.ejca.2018.12.003","journal-title":"Eur J Cancer"},{"key":"4556_CR17","doi-asserted-by":"publisher","unstructured":"Britten-Jones L, Samra S, Goltsman D, Sandler G, Gild ML, Girgis CM (2025) Biochemical and structural response in patients with tall cell papillary thyroid cancer: a dual centre retrospective study: Early Recurrence in Tall Cell PTC Eur Arch Otorhinolaryngol. https:\/\/doi.org\/10.1007\/s00405-025-09426-5","DOI":"10.1007\/s00405-025-09426-5"},{"key":"4556_CR18","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/PAS.0000000000000793","volume":"41","author":"JM Cameselle-Teijeiro","year":"2017","unstructured":"Cameselle-Teijeiro JM, Rodriguez-Perez I, Celestino R, Eloy C, Piso-Neira M, Abdulkader-Nallib I, Soares P, Sobrinho-Simoes M (2017) Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases. Am J Surg Pathol 41:854\u2013860. https:\/\/doi.org\/10.1097\/PAS.0000000000000793","journal-title":"Am J Surg Pathol"},{"key":"4556_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N (2014) Integrated genomic characterization of papillary. thyroid carcinoma Cell 159:676\u2013690. https:\/\/doi.org\/10.1016\/j.cell.2014.09.050","journal-title":"thyroid carcinoma Cell"},{"key":"4556_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S2213-8587(24)00310-3","volume":"13","author":"MM Chen","year":"2025","unstructured":"Chen MM, Luu M, Sacks WL, Orloff L, Wallner LP, Clair JM, Pitt SC, Ho AS, Zumsteg ZS (2025) Trends in incidence, metastasis, and mortality from thyroid cancer in the USA from 1975 to 2019: a population-based study of age, period, and cohort effects. Lancet Diabetes Endocrinol 13:188\u2013195. https:\/\/doi.org\/10.1016\/S2213-8587(24)00310-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4556_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00428-002-0701-2","volume":"442","author":"P Collini","year":"2003","unstructured":"Collini P, Sampietro G, Rosai J, Pilotti S (2003) Minimally invasive (encapsulated) follicular carcinoma of the thyroid gland is the low-risk counterpart of widely invasive follicular carcinoma but not of insular carcinoma. Virchows Arch 442:71\u201376. https:\/\/doi.org\/10.1007\/s00428-002-0701-2","journal-title":"Virchows Arch"},{"key":"4556_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12105-019-01048-8","volume":"14","author":"V Cracolici","year":"2020","unstructured":"Cracolici V, Parilla M, Henriksen KJ, Cipriani NA (2020) An Evaluation of CD61 Immunohistochemistry in Identification of Vascular Invasion in Follicular Thyroid Neoplasms. Head Neck Pathol 14:399\u2013405. https:\/\/doi.org\/10.1007\/s12105-019-01048-8","journal-title":"Head Neck Pathol"},{"key":"4556_CR23","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1089\/thy.2015.0101","volume":"25","author":"D de Biase","year":"2015","unstructured":"de Biase D, Gandolfi G, Ragazzi M, Eszlinger M, Sancisi V, Gugnoni M, Visani M, Pession A, Casadei G, Durante C, Costante G, Bruno R, Torlontano M, Paschke R, Filetti S, Piana S, Frasoldati A, Tallini G, Ciarrocchi A (2015) TERT Promoter Mutations in Papillary. Thyroid Microcarcinomas Thyroid 25:1013\u20131019. https:\/\/doi.org\/10.1089\/thy.2015.0101","journal-title":"Thyroid Microcarcinomas Thyroid"},{"key":"4556_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1309\/AJCPXE3PUBWVZCGZ","volume":"137","author":"ML Enriquez","year":"2012","unstructured":"Enriquez ML, Baloch ZW, Montone KT, Zhang PJ, LiVolsi VA (2012) CDX2 expression in columnar cell variant of papillary thyroid carcinoma. Am J Clin Pathol 137:722\u2013726. https:\/\/doi.org\/10.1309\/AJCPXE3PUBWVZCGZ","journal-title":"Am J Clin Pathol"},{"key":"4556_CR25","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/00000478-199610000-00005","volume":"20","author":"HL Evans","year":"1996","unstructured":"Evans HL (1996) Encapsulated columnar-cell neoplasms of the thyroid. A report of four cases suggesting a favorable prognosis. Am J Surg Pathol 20:1205\u20131211. https:\/\/doi.org\/10.1097\/00000478-199610000-00005","journal-title":"Am J Surg Pathol"},{"key":"4556_CR26","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/01.sla.0000157317.60536.08","volume":"241","author":"L Falvo","year":"2005","unstructured":"Falvo L, Catania A, D\u2019Andrea V, Marzullo A, Giustiniani MC, De Antoni E (2005) Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma. Ann Surg 241:640\u2013646. https:\/\/doi.org\/10.1097\/01.sla.0000157317.60536.08","journal-title":"Ann Surg"},{"key":"4556_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.23736\/S2724-6507.22.03749-6","volume":"49","author":"L Fonseca","year":"2024","unstructured":"Fonseca L, Borges Duarte D, Brandao JR, Alves Pereira C, Amado A, Gouveia P, Couto Carvalho A, Borges F, Freitas C (2024) Papillary thyroid carcinoma: the impact of histologic vascular invasion. Minerva Endocrinol (Torino) 49:69\u201375. https:\/\/doi.org\/10.23736\/S2724-6507.22.03749-6","journal-title":"Minerva Endocrinol (Torino)"},{"key":"4556_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jamcollsurg.2003.11.012","volume":"198","author":"JC Furlan","year":"2004","unstructured":"Furlan JC, Bedard YC, Rosen IB (2004) Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. J Am Coll Surg 198:341\u2013348. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2003.11.012","journal-title":"J Am Coll Surg"},{"key":"4556_CR29","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1016\/j.mayocp.2021.04.028","volume":"96","author":"N Genere","year":"2021","unstructured":"Genere N, El Kawkgi OM, Giblon RE, Vaccarella S, Morris JC, Hay ID, Brito JP (2021) Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century: A Population-Based Study. Mayo Clin Proc 96:2823\u20132830. https:\/\/doi.org\/10.1016\/j.mayocp.2021.04.028","journal-title":"Mayo Clin Proc"},{"key":"4556_CR30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1089\/thy.2007.0061","volume":"17","author":"RA Ghossein","year":"2007","unstructured":"Ghossein RA, Leboeuf R, Patel KN, Rivera M, Katabi N, Carlson DL, Tallini G, Shaha A, Singh B, Tuttle RM (2007) Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications. Thyroid 17:655\u2013661. https:\/\/doi.org\/10.1089\/thy.2007.0061","journal-title":"Thyroid"},{"key":"4556_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1089\/thy.2023.0032","volume":"33","author":"R Ghossein","year":"2023","unstructured":"Ghossein R, Ganly I, Tuttle RM, Xu B (2023) Large (>\u20094\u00a0cm) Intrathyroidal Encapsulated Well-Differentiated Follicular Cell-Derived Carcinoma Without Vascular Invasion May Have Negligible Risk of Recurrence Even When Treated with. Lobectomy Alone Thyroid 33:586\u2013592. https:\/\/doi.org\/10.1089\/thy.2023.0032","journal-title":"Lobectomy Alone Thyroid"},{"key":"4556_CR32","doi-asserted-by":"publisher","unstructured":"Ghossein R, Katabi N, Dogan S, Shaha AR, Tuttle RM, Fagin JA, Ganly I, Xu B (2024) Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients. Histopathology 84:1130\u20131138. https:\/\/doi.org\/10.1111\/his.15157","DOI":"10.1111\/his.15157"},{"key":"4556_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated. Thyroid Cancer Thyroid 26:1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid Cancer Thyroid"},{"key":"4556_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.surg.2015.05.046","volume":"159","author":"ID Hay","year":"2016","unstructured":"Hay ID, Johnson TR, Thompson GB, Sebo TJ, Reinalda MS (2016) Minimal extrathyroid extension in papillary thyroid carcinoma does not result in increased rates of either cause-specific mortality or postoperative. tumor recurrence Surg 159:11\u201319. https:\/\/doi.org\/10.1016\/j.surg.2015.05.046","journal-title":"tumor recurrence Surg"},{"key":"4556_CR35","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.2147\/CMAR.S390468","volume":"14","author":"Q He","year":"2022","unstructured":"He Q, Ji F, Fu X, Li Z, Qiu X (2022) Micro Extrathyroidal Extension in Risk Stratification for Papillary Thyroid Carcinoma: Should It Be in the Intermediate-Risk or High-Risk Group? A Single-Center Retrospective Study. Cancer Manag Res 14:3181\u20133190. https:\/\/doi.org\/10.2147\/CMAR.S390468","journal-title":"Cancer Manag Res"},{"key":"4556_CR36","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1089\/thy.2017.0280","volume":"27","author":"JC Hernandez-Prera","year":"2017","unstructured":"Hernandez-Prera JC, Machado RA, Asa SL, Baloch Z, Faquin WC, Ghossein R, LiVolsi VA, Lloyd RV, Mete O, Nikiforov YE, Seethala RR, Suster S, Thompson LD, Turk AT, Sadow PM, Urken ML, Wenig BM (2017) Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus? Thyroid 27:1498\u20131504. https:\/\/doi.org\/10.1089\/thy.2017.0280","journal-title":"Thyroid"},{"key":"4556_CR37","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/cncr.21739","volume":"106","author":"D Hiltzik","year":"2006","unstructured":"Hiltzik D, Carlson DL, Tuttle RM, Chuai S, Ishill N, Shaha A, Shah JP, Singh B, Ghossein RA (2006) Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58. patients Cancer 106:1286\u20131295. https:\/\/doi.org\/10.1002\/cncr.21739","journal-title":"patients Cancer"},{"key":"4556_CR38","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1507\/endocrj.ej12-0454","volume":"60","author":"Y Ito","year":"2013","unstructured":"Ito Y, Hirokawa M, Masuoka H, Yabuta T, Fukushima M, Kihara M, Higashiyama T, Takamura Y, Kobayashi K, Miya A, Miyauchi A (2013) Distant metastasis at diagnosis and large tumor size are significant prognostic factors of widely invasive follicular thyroid carcinoma. Endocr J 60:829\u2013833. https:\/\/doi.org\/10.1507\/endocrj.ej12-0454","journal-title":"Endocr J"},{"key":"4556_CR39","doi-asserted-by":"publisher","first-page":"325602","DOI":"10.4061\/2010\/325602","volume":"2010","author":"S Jalisi","year":"2010","unstructured":"Jalisi S, Ainsworth T, Lavalley M (2010) Prognostic outcomes of tall cell variant papillary thyroid cancer: a meta-analysis. J Thyroid Res 2010:325602. https:\/\/doi.org\/10.4061\/2010\/325602","journal-title":"J Thyroid Res"},{"key":"4556_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/his.14374","volume":"79","author":"T Janovitz","year":"2021","unstructured":"Janovitz T, Williamson DFK, Wong KS, Dong F, Barletta JA (2021) Genomic profile of columnar cell variant of papillary. thyroid carcinoma Histopathology 79:491\u2013498. https:\/\/doi.org\/10.1111\/his.14374","journal-title":"thyroid carcinoma Histopathology"},{"key":"4556_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00268-022-06696-6","volume":"47","author":"D Leong","year":"2023","unstructured":"Leong D, Gill AJ, Turchini J, Waller M, Clifton-Bligh R, Glover A, Sywak M, Sidhu S (2023) The Prognostic Impact of Extent of Vascular Invasion in Follicular Thyroid Carcinoma. World J Surg 47:412\u2013420. https:\/\/doi.org\/10.1007\/s00268-022-06696-6","journal-title":"World J Surg"},{"key":"4556_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.amjsurg.2024.03.022","volume":"234","author":"D Leong","year":"2024","unstructured":"Leong D, Leslie C, Laurie B, Hou L, Keyser J, Yew MK, Ryan S, Nguyen H, Lisewski D (2024) Tumour size predicts risk of recurrence in tall cell subtype papillary thyroid carcinoma. Am J Surg 234:58\u201361. https:\/\/doi.org\/10.1016\/j.amjsurg.2024.03.022","journal-title":"Am J Surg"},{"key":"4556_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/MLG.0b013e318156f6c3","volume":"118","author":"AK Leung","year":"2008","unstructured":"Leung AK, Chow SM, Law SC (2008) Clinical features and outcome of the tall cell variant of papillary. thyroid carcinoma Laryngoscope 118:32\u201338. https:\/\/doi.org\/10.1097\/MLG.0b013e318156f6c3","journal-title":"thyroid carcinoma Laryngoscope"},{"key":"4556_CR44","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1097\/SLA.0000000000003632","volume":"274","author":"J Limberg","year":"2021","unstructured":"Limberg J, Ullmann TM, Stefanova D, Buicko JL, Finnerty BM, Zarnegar R, Fahey TJ 3rd, Beninato T (2021) Does Aggressive Variant Histology Without Invasive Features Predict Overall Survival in Papillary Thyroid Cancer? A National Cancer Database. Anal Ann Surg 274:e276\u2013e281. https:\/\/doi.org\/10.1097\/SLA.0000000000003632","journal-title":"Anal Ann Surg"},{"key":"4556_CR45","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1001\/jamaoncol.2016.3288","volume":"3","author":"R Liu","year":"2017","unstructured":"Liu R, Bishop J, Zhu G, Zhang T, Ladenson PW, Xing M (2017) Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer: Genetic Duet of BRAF and TERT Promoter Mutations in Thyroid Cancer Mortality. JAMA Oncol 3:202\u2013208. https:\/\/doi.org\/10.1001\/jamaoncol.2016.3288","journal-title":"JAMA Oncol"},{"key":"4556_CR46","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1089\/thy.2013.0573","volume":"24","author":"CC Lubitz","year":"2014","unstructured":"Lubitz CC, Economopoulos KP, Pawlak AC, Lynch K, Dias-Santagata D, Faquin WC, Sadow PM (2014) Hobnail variant of papillary thyroid carcinoma: an institutional case series and. Mol profile Thyroid 24:958\u2013965. https:\/\/doi.org\/10.1089\/thy.2013.0573","journal-title":"Mol profile Thyroid"},{"key":"4556_CR47","doi-asserted-by":"publisher","first-page":"549882","DOI":"10.3389\/fonc.2020.549882","volume":"10","author":"Y Luo","year":"2020","unstructured":"Luo Y, Jiang H, Xu W, Wang X, Ma B, Liao T, Wang Y (2020) Clinical, Pathological, and Molecular Characteristics Correlating to the Occurrence of Radioiodine Refractory Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis. Front Oncol 10:549882. https:\/\/doi.org\/10.3389\/fonc.2020.549882","journal-title":"Front Oncol"},{"key":"4556_CR48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/00313020220131291","volume":"34","author":"KT Mai","year":"2002","unstructured":"Mai KT, Khanna P, Yazdi HM, Perkins DG, Veinot JP, Thomas J, Lamba M, Nair BD (2002) Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular. Hurthle cell papillary thyroid carcinoma Pathol 34:239\u2013244. https:\/\/doi.org\/10.1080\/00313020220131291","journal-title":"Hurthle cell papillary thyroid carcinoma Pathol"},{"key":"4556_CR49","doi-asserted-by":"publisher","first-page":"104792","DOI":"10.1016\/j.critrevonc.2025.104792","volume":"213","author":"T Maloberti","year":"2025","unstructured":"Maloberti T, Repaci A, Poppi L, Di Paola FJ, Calafato G, Coluccelli S, Carosi F, Colapinto A, Colombero S, Credi G, Tallini G, Pantaleo MA, Nannini M, de Biase D (2025) Exploring the role of TERT in thyroid Cancer: A systematic review. Crit Rev Oncol Hematol 213:104792. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104792","journal-title":"Crit Rev Oncol Hematol"},{"key":"4556_CR50","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/modpathol.2011.119","volume":"24","author":"O Mete","year":"2011","unstructured":"Mete O, Asa SL (2011) Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24:1545\u20131552. https:\/\/doi.org\/10.1038\/modpathol.2011.119","journal-title":"Mod Pathol"},{"key":"4556_CR51","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1245\/s10434-009-0832-7","volume":"17","author":"O Mete","year":"2010","unstructured":"Mete O, Rotstein L, Asa SL (2010) Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol 17:386\u2013391. https:\/\/doi.org\/10.1245\/s10434-009-0832-7","journal-title":"Ann Surg Oncol"},{"key":"4556_CR52","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/PAP.0000000000000184","volume":"25","author":"MC Nath","year":"2018","unstructured":"Nath MC, Erickson LA (2018) Aggressive Variants of Papillary Thyroid Carcinoma: Hobnail, Tall Cell, Columnar, and Solid. Adv Anat Pathol 25:172\u2013179. https:\/\/doi.org\/10.1097\/PAP.0000000000000184","journal-title":"Adv Anat Pathol"},{"key":"4556_CR53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/s0002-9610(01)00843-1","volume":"183","author":"T Nishida","year":"2002","unstructured":"Nishida T, Katayama S, Tsujimoto M (2002) The clinicopathological significance of histologic vascular invasion in differentiated thyroid carcinoma. Am J Surg 183:80\u201386. https:\/\/doi.org\/10.1016\/s0002-9610(01)00843-1","journal-title":"Am J Surg"},{"key":"4556_CR54","doi-asserted-by":"publisher","first-page":"e4109","DOI":"10.1210\/clinem\/dgab388","volume":"106","author":"AM Poma","year":"2021","unstructured":"Poma AM, Viola D, Macerola E, Proietti A, Molinaro E, De Vietro D, Elisei R, Materazzi G, Miccoli P, Basolo F, Ugolini C (2021) Tall cell percentage alone in PTC without aggressive features should not guide patients\u2019 clinical management. J Clin Endocrinol Metab 106:e4109\u2013e4117. https:\/\/doi.org\/10.1210\/clinem\/dgab388","journal-title":"J Clin Endocrinol Metab"},{"key":"4556_CR55","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1089\/thy.2023.0350","volume":"34","author":"AM Poma","year":"2024","unstructured":"Poma AM, Macerola E, Ghossein RA, Tallini G, Basolo F (2024) Prevalence of Differentiated High-Grade Thyroid Carcinoma Among Well-Differentiated Tumors: A Systematic Review and Meta-Analysis. Thyroid 34:314\u2013323. https:\/\/doi.org\/10.1089\/thy.2023.0350","journal-title":"Thyroid"},{"key":"4556_CR56","doi-asserted-by":"publisher","first-page":"e66913","DOI":"10.7759\/cureus.66913","volume":"16","author":"S Puvvadi","year":"2024","unstructured":"Puvvadi S, Reddy N, Jundi R, Chang A, Silberstein PT, Hsia B (2024) Demographic and Prognostic Factors of the Columnar Cell Variant of Papillary Thyroid Carcinoma: A National Cancer. Database Study Cureus 16:e66913. https:\/\/doi.org\/10.7759\/cureus.66913","journal-title":"Database Study Cureus"},{"key":"4556_CR57","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1089\/thy.2010.0174","volume":"20","author":"M Rivera","year":"2010","unstructured":"Rivera M, Ricarte-Filho J, Tuttle RM, Ganly I, Shaha A, Knauf J, Fagin J, Ghossein R (2010) Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of. extrathyroid Ext Thyroid 20:1085\u20131093. https:\/\/doi.org\/10.1089\/thy.2010.0174","journal-title":"extrathyroid Ext Thyroid"},{"key":"4556_CR58","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.humpath.2009.08.011","volume":"41","author":"M Rivera","year":"2010","unstructured":"Rivera M, Ricarte-Filho J, Patel S, Tuttle M, Shaha A, Shah JP, Fagin JA, Ghossein RA (2010) Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate\/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol 41:172\u2013180. https:\/\/doi.org\/10.1016\/j.humpath.2009.08.011","journal-title":"Hum Pathol"},{"key":"4556_CR59","doi-asserted-by":"publisher","first-page":"154012","DOI":"10.1016\/j.prp.2022.154012","volume":"236","author":"S Samankan","year":"2022","unstructured":"Samankan S, Militello L, Seo G, Everest S, O\u2019Malley Q, Spaulding SL, Xing M, Matloob A, Beute J, Chai R, Doyle S, Urken ML, Brandwein-Weber M (2022) Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10% cut-point on multivariate analysis. Pathol Res Pract 236:154012. https:\/\/doi.org\/10.1016\/j.prp.2022.154012","journal-title":"Pathol Res Pract"},{"key":"4556_CR60","doi-asserted-by":"publisher","unstructured":"Schipor S, Publik MA, Manda D, Ceausu M (2025) Aggressive thyroid carcinomas clinical and molecular features: a systematic review. Int J Mol Sci 26. https:\/\/doi.org\/10.3390\/ijms26125535","DOI":"10.3390\/ijms26125535"},{"key":"4556_CR61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/thy.2024.0499","volume":"35","author":"DW Scholfield","year":"2025","unstructured":"Scholfield DW, Xu B, Levyn H, Eagan A, Shaha AR, Shah JP, Tuttle RM, Fagin JA, Wong RJ, Patel SG, Ghossein R, Ganly I (2025) High-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Carcinoma: Correlating Extent of Invasion and Mutation Profile with. Oncologic Outcome Thyroid 35:153\u2013165. https:\/\/doi.org\/10.1089\/thy.2024.0499","journal-title":"Oncologic Outcome Thyroid"},{"key":"4556_CR62","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/hed.21494","volume":"33","author":"CE Silver","year":"2011","unstructured":"Silver CE, Owen RP, Rodrigo JP, Rinaldo A, Devaney KO, Ferlito A (2011) Aggressive variants of papillary thyroid carcinoma. Head Neck 33:1052\u20131059. https:\/\/doi.org\/10.1002\/hed.21494","journal-title":"Head Neck"},{"key":"4556_CR63","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12022-021-09666-1","volume":"32","author":"P Soares","year":"2021","unstructured":"Soares P, Povoa AA, Melo M, Vinagre J, Maximo V, Eloy C, Cameselle-Teijeiro JM, Sobrinho-Simoes M (2021) Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS\/BRAF-like Tumor Designations to Molecular Risk. Stratification Endocr Pathol 32:44\u201362. https:\/\/doi.org\/10.1007\/s12022-021-09666-1","journal-title":"Stratification Endocr Pathol"},{"key":"4556_CR64","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1530\/EJE-17-0991","volume":"179","author":"E Song","year":"2018","unstructured":"Song E, Jeon MJ, Oh HS, Han M, Lee YM, Kim TY, Chung KW, Kim WB, Shong YK, Song DE, Kim WG (2018) Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma? Eur J Endocrinol 179:135\u2013142. https:\/\/doi.org\/10.1530\/EJE-17-0991","journal-title":"Eur J Endocrinol"},{"key":"4556_CR65","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1245\/s10434-019-07778-x","volume":"26","author":"E Song","year":"2019","unstructured":"Song E, Kim WW, Jeon MJ, Sung TY, Song DE, Kim TY, Chung KW, Kim WB, Shong YK, Hong SJ, Lee YM, Kim WG (2019) Clinical Significance of Gross Invasion of Strap Muscles in Patients With 1- to 4-cm-Sized Papillary Thyroid Carcinoma Undergoing Lobectomy. Ann Surg Oncol 26:4466\u20134471. https:\/\/doi.org\/10.1245\/s10434-019-07778-x","journal-title":"Ann Surg Oncol"},{"key":"4556_CR66","doi-asserted-by":"publisher","unstructured":"Su H, Li Y, Men Q, Hao J, Zhang F (2025) Analysis of risk factors for distant metastasis of column cell subtypes of thyroid papillary carcinoma Eur Arch Otorhinolaryngol. https:\/\/doi.org\/10.1007\/s00405-025-09394-w","DOI":"10.1007\/s00405-025-09394-w"},{"key":"4556_CR67","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries CA. Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"Cancer J Clin"},{"key":"4556_CR68","doi-asserted-by":"publisher","first-page":"22023","DOI":"10.18632\/oncotarget.15786","volume":"8","author":"L Teng","year":"2017","unstructured":"Teng L, Deng W, Lu J, Zhang J, Ren X, Duan H, Chuai S, Duan F, Gao W, Lu T, Wu H, Liang Z (2017) Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic. thyroid carcinoma Oncotarget 8:22023\u201322033. https:\/\/doi.org\/10.18632\/oncotarget.15786","journal-title":"thyroid carcinoma Oncotarget"},{"key":"4556_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.humpath.2024.01.002","volume":"144","author":"I Tondi Resta","year":"2024","unstructured":"Tondi Resta I, Gubbiotti MA, Montone KT, Livolsi VA, Baloch ZW (2024) Differentiated high grade thyroid carcinomas: Diagnostic consideration and clinical features. Hum Pathol 144:53\u201360. https:\/\/doi.org\/10.1016\/j.humpath.2024.01.002","journal-title":"Hum Pathol"},{"key":"4556_CR70","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12022-023-09788-8","volume":"34","author":"J Turchini","year":"2023","unstructured":"Turchini J, Fuchs TL, Chou A, Sioson L, Clarkson A, Sheen A, Delbridge L, Glover A, Sywak M, Sidhu S, Gill AJ (2023) A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma-How Much? How Tall? And When Is It Relevant? Endocr Pathol 34:461\u2013470. https:\/\/doi.org\/10.1007\/s12022-023-09788-8","journal-title":"Endocr Pathol"},{"key":"4556_CR71","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/thy.2018.0286","volume":"29","author":"AT Turk","year":"2019","unstructured":"Turk AT, Asa SL, Baloch ZW, Faquin WC, Fellegara G, Ghossein RA, Giordano TJ, LiVolsi VA, Lloyd R, Mete O, Rosai J, Suster S, Thompson LDR, Wenig BM (2019) Interobserver Variability in the Histopathologic Assessment of Extrathyroidal Extension of Well Differentiated Thyroid Carcinoma Supports the New American Joint Committee on Cancer Eighth Edition Criteria for. Tumor Staging Thyroid 29:619\u2013624. https:\/\/doi.org\/10.1089\/thy.2018.0286","journal-title":"Tumor Staging Thyroid"},{"key":"4556_CR72","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/PAS.0b013e3180309e6a","volume":"31","author":"M Volante","year":"2007","unstructured":"Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256\u20131264. https:\/\/doi.org\/10.1097\/PAS.0b013e3180309e6a","journal-title":"Am J Surg Pathol"},{"key":"4556_CR73","doi-asserted-by":"publisher","unstructured":"Vuong HG, Long NP, Anh NH, Nghi TD, Hieu MV, Hung LP, Nakazawa T, Katoh R, Kondo T (2018) Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis. Endocr Connect 7:R286\u2013R293. https:\/\/doi.org\/10.1530\/EC-18-0333","DOI":"10.1530\/EC-18-0333"},{"key":"4556_CR74","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1089\/thy.2017.0248","volume":"28","author":"S Watutantrige-Fernando","year":"2018","unstructured":"Watutantrige-Fernando S, Vianello F, Barollo S, Bertazza L, Galuppini F, Cavedon E, Censi S, Benna C, Ide EC, Parisi A, Nacamulli D, Iacobone M, Pennelli G, Mian C (2018) The Hobnail Variant of Papillary Thyroid Carcinoma: Clinical\/Molecular Characteristics of a Large Monocentric Series and Comparison with. Conventional Histotypes Thyroid 28:96\u2013103. https:\/\/doi.org\/10.1089\/thy.2017.0248","journal-title":"Conventional Histotypes Thyroid"},{"key":"4556_CR75","first-page":"740","volume":"82","author":"BM Wenig","year":"1998","unstructured":"Wenig BM, Thompson LD, Adair CF, Shmookler B, Heffess CS (1998) Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16. cases Cancer 82:740\u2013753","journal-title":"cases Cancer"},{"key":"4556_CR76","doi-asserted-by":"publisher","first-page":"336","DOI":"10.21053\/ceo.2024.00162","volume":"17","author":"HR Won","year":"2024","unstructured":"Won HR, Kim JW, Son HO, Yi S, Chang JW, Koo BS (2024) Clinical Significance of Gross Extrathyroidal Extension to Only the Strap Muscle According to Tumor Size in Differentiated Thyroid Cancer: A Systematic Review and Meta-Analysis. Clin Exp Otorhinolaryngol 17:336\u2013345. https:\/\/doi.org\/10.21053\/ceo.2024.00162","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"4556_CR77","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/his.14042","volume":"76","author":"KS Wong","year":"2020","unstructured":"Wong KS, Chen TY, Higgins SE, Howitt BE, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, Doherty GM, Barletta JA (2020) A potential diagnostic pitfall for hobnail variant of papillary. thyroid carcinoma Histopathology 76:707\u2013713. https:\/\/doi.org\/10.1111\/his.14042","journal-title":"thyroid carcinoma Histopathology"},{"key":"4556_CR78","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1089\/thy.2020.0668","volume":"31","author":"KS Wong","year":"2021","unstructured":"Wong KS, Dong F, Telatar M, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, Doherty GM, Afkhami M, Barletta JA (2021) Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features. Outcome Thyroid 31:933\u2013940. https:\/\/doi.org\/10.1089\/thy.2020.0668","journal-title":"Outcome Thyroid"},{"key":"4556_CR79","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/JCO.2014.56.8253","volume":"33","author":"M Xing","year":"2015","unstructured":"Xing M, Alzahrani AS, Carson KA, Shong YK, Kim TY, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, Robenshtok E, Fagin JA, Puxeddu E, Fugazzola L, Czarniecka A, Jarzab B, O\u2019Neill CJ, Sywak MS, Lam AK, Riesco-Eizaguirre G, Santisteban P, Nakayama H, Clifton-Bligh R, Tallini G, Holt EH, Sykorova V (2015) Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J Clin Oncol 33:42\u201350. https:\/\/doi.org\/10.1200\/JCO.2014.56.8253","journal-title":"J Clin Oncol"},{"key":"4556_CR80","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.humpath.2015.08.015","volume":"46","author":"B Xu","year":"2015","unstructured":"Xu B, Wang L, Tuttle RM, Ganly I, Ghossein R (2015) Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276. cases Hum Pathol 46:1789\u20131798. https:\/\/doi.org\/10.1016\/j.humpath.2015.08.015","journal-title":"cases Hum Pathol"},{"key":"4556_CR81","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1089\/thy.2016.0247","volume":"26","author":"B Xu","year":"2016","unstructured":"Xu B, Ibrahimpasic T, Wang L, Sabra MM, Migliacci JC, Tuttle RM, Ganly I, Ghossein R (2016) Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived. Thyroid Carcinomas Thyroid 26:1588\u20131597. https:\/\/doi.org\/10.1089\/thy.2016.0247","journal-title":"Thyroid Carcinomas Thyroid"},{"key":"4556_CR82","doi-asserted-by":"publisher","unstructured":"Xu B, David J, Dogan S, Landa I, Katabi N, Saliba M, Khimraj A, Sherman EJ, Tuttle RM, Tallini G, Ganly I, Fagin JA, Ghossein RA (2022) Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases. Histopathology 80:322\u2013337. https:\/\/doi.org\/10.1111\/his.14550","DOI":"10.1111\/his.14550"},{"key":"4556_CR83","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/his.15285","volume":"85","author":"B Xu","year":"2024","unstructured":"Xu B, Roy D, Serrette R, Ghossein R (2024) Defining angioinvasion and lymphatic invasion in papillary thyroid carcinoma: morphological criteria, utility of D2-40\/CD31\/ERG immunohistochemistry and correlation with clinicopathological characteristics. Histopathology 85:950\u2013958. https:\/\/doi.org\/10.1111\/his.15285","journal-title":"Histopathology"},{"key":"4556_CR84","doi-asserted-by":"publisher","unstructured":"Yadav V, Lahiri A, Pasricha S, Arora V, Sharma P, Chowdhury S, Dewan AK (2025) Distinctive hobnail subtype of papillary thyroid carcinoma: a case series and short review of literature Hormones (Athens). https:\/\/doi.org\/10.1007\/s42000-025-00692-w","DOI":"10.1007\/s42000-025-00692-w"},{"key":"4556_CR85","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1210\/clinem\/dgad689","volume":"109","author":"H Yamazaki","year":"2024","unstructured":"Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M, Rino Y, Saito A, Ito K (2024) Role of the Degree of Vascular Invasion in Predicting Prognosis of Follicular Thyroid Carcinoma. J Clin Endocrinol Metab 109:1291\u20131300. https:\/\/doi.org\/10.1210\/clinem\/dgad689","journal-title":"J Clin Endocrinol Metab"},{"key":"4556_CR86","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1159\/000443032","volume":"38","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Liu SZ, Zhang Q, Guan YX, Chen QJ, Zhu QY (2016) Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma. Cell Physiol Biochem 38:763\u2013776. https:\/\/doi.org\/10.1159\/000443032","journal-title":"Cell Physiol Biochem"},{"key":"4556_CR87","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12885-020-06915-0","volume":"20","author":"X Zhou","year":"2020","unstructured":"Zhou X, Zheng Z, Chen C, Zhao B, Cao H, Li T, Liu X, Wang W, Li Y (2020) Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study. BMC Cancer 20:407. https:\/\/doi.org\/10.1186\/s12885-020-06915-0","journal-title":"BMC Cancer"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04556-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04556-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04556-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:54:27Z","timestamp":1781344467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04556-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4556"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04556-5","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no conflicts of interest relevant to the content of this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}